Our division’s faculty combine clinical work with innovative research programs, advancing the new approaches to diagnosing and treating childhood cancer and blood diseases. We approach our work collaboratively. Our team of physicians who care for patients with a disease, our basic scientists who investigate the condition's molecular basis, our epidemiologists who study its effect on populations and our translational infrastructure all allow us to expedite the translation of our research into novel therapies aimed at improving patient care.

Our faculty direct sixteen basic science and translational research labs. Their groundbreaking work focuses on childhood leukemia, pediatric cancer immunotherapy, blood cell development (hematopoiesis), cancer cell proliferation, and the molecular mechanisms underlying bone marrow failure. Together we strive towards a singular goal - expediting the translation of our research into novel therapies aimed at improving patient care.